Doogan Declan's most recent trade in Tenax Therapeutics Inc was a trade of 80,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenax Therapeutics Inc | Doogan Declan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Declan Doogan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Declan Doogan | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2021 | 567,871 | 2,502,129 (37%) | 8% | 0 | Common Stock |